SenesTech, Inc. (SNES): Price and Financial Metrics


SenesTech, Inc. (SNES): $1.49

-0.03 (-1.97%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SNES Stock Summary

  • With a market capitalization of $2,997,195, SENESTECH INC has a greater market value than only 0.71% of US stocks.
  • In terms of volatility of its share price, SNES is more volatile than 97.95% of stocks we're observing.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for SNES comes in at -140% -- higher than that of only 4.32% of stocks in our set.
  • Stocks that are quantitatively similar to SNES, based on their financial statements, market capitalization, and price volatility, are ECOR, REFR, KVHI, RWLK, and PLAB.
  • Visit SNES's SEC page to see the company's official filings. To visit the company's web site, go to www.senestech.com.

SNES Valuation Summary

  • SNES's EV/EBIT ratio is 0.1; this is 99.09% lower than that of the median Basic Materials stock.
  • SNES's price/earnings ratio has moved up 4.3 over the prior 77 months.

Below are key valuation metrics over time for SNES.

Stock Date P/S P/B P/E EV/EBIT
SNES 2023-03-24 2.9 0.6 -0.3 0.1
SNES 2023-03-23 2.9 0.6 -0.3 0.1
SNES 2023-03-22 3.8 0.7 -0.4 0.1
SNES 2023-03-21 3.4 0.7 -0.4 0.1
SNES 2023-03-20 3.2 0.6 -0.3 0.1
SNES 2023-03-17 3.3 0.6 -0.4 0.1

SNES Growth Metrics

    Its 5 year revenue growth rate is now at -49.37%.
  • The 4 year net cashflow from operations growth rate now stands at -19.19%.
  • The 3 year price growth rate now stands at -98.5%.
Over the past 18 months, SNES's revenue has gone up $558,000.

The table below shows SNES's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 0.891 -8.113 -10.041
2022-06-30 0.824 -7.926 -9.648
2022-03-31 0.707 -7.793 -8.779
2021-12-31 0.6 -7.779 -8.268
2021-09-30 0.528 -7.645 -7.868
2021-06-30 0.422 -7.536 -7.534

SNES Price Target

For more insight on analysts targets of SNES, see our SNES price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $4.00 Average Broker Recommendation 1.5 (Moderate Buy)

SNES Stock Price Chart Interactive Chart >

Price chart for SNES

SNES Price/Volume Stats

Current price $1.49 52-week high $16.00
Prev. close $1.52 52-week low $1.31
Day low $1.45 Volume 56,900
Day high $1.53 Avg. volume 186,426
50-day MA $2.48 Dividend yield N/A
200-day MA $5.96 Market Cap 3.06M

SenesTech, Inc. (SNES) Company Bio


SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It develops a pipeline of fertility control and animal health products, such as ContraPest, plant-based fertility control, feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was founded in 2004 and is based in Flagstaff, Arizona.


SNES Latest News Stream


Event/Time News Detail
Loading, please wait...

SNES Latest Social Stream


Loading social stream, please wait...

View Full SNES Social Stream

Latest SNES News From Around the Web

Below are the latest news stories about SENESTECH INC that investors may wish to consider to help them evaluate SNES as an investment opportunity.

TIME Magazine Takes a Closer Look at ContraPest as a Solution to Global Rat Infestations

SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, were featured in TIME Magazine as an innovative approach to dealing with global rat infestations.

Yahoo | March 29, 2023

SenesTech, Inc. (NASDAQ:SNES) Q4 2022 Earnings Call Transcript

SenesTech, Inc. (NASDAQ:SNES) Q4 2022 Earnings Call Transcript March 16, 2023 Operator: Good afternoon and welcome to the SenesTech, Incorporated Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call. Please note, this event is being recorded. I would now like to turn the conference over to Robert Blum with Lytham Partners. Please go ahead. […]

Yahoo | March 20, 2023

Q4 2022 Senestech Inc Earnings Call

Q4 2022 Senestech Inc Earnings Call

Yahoo | March 17, 2023

SenesTech Announces 2022 Financial Results

SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced 2022 financial results, with products sales increasing 77% compared to the prior year.

Yahoo | March 16, 2023

SenesTech Working with TriptoBIO on Biosynthetic Triptolide

SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today confirmed news reports that the Company has been working with the Danish company TriptoBIO on the development of biosynthetic triptolide, one of the active ingredients in ContraPest.

Yahoo | March 14, 2023

Read More 'SNES' Stories Here

SNES Price Returns

1-mo -28.71%
3-mo -51.78%
6-mo -78.74%
1-year -89.79%
3-year -96.40%
5-year -99.27%
YTD -51.78%
2022 -84.22%
2021 -43.26%
2020 -84.32%
2019 -5.98%
2018 -18.75%

Continue Researching SNES

Want to see what other sources are saying about SenesTech Inc's financials and stock price? Try the links below:

SenesTech Inc (SNES) Stock Price | Nasdaq
SenesTech Inc (SNES) Stock Quote, History and News - Yahoo Finance
SenesTech Inc (SNES) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8778 seconds.